Born in Murcia (Spain), Dr. Jose Manuel Martínez completed his studies at the Faculty of Medicine in the region and underwent specialized training in obstetrics and gynecology at the Santa Lucía University Hospital in Cartagena.
After completing his residency, and while balancing a full-time role as a specialist at the public hospital in Cartagena, he decided to enhance his academic background by pursuing two official postgraduate programs during the same academic year: Clinical Medicine Research (Miguel Hernández University, earning the "extraordinary master's award”); and Advanced Medical Competencies in the field of Oncological Gynecology and Multidisciplinary Breast Pathology (University of Barcelona).
Currently, his work is divided into three main areas:
As a healthcare practitioner at Bellvitge University Hospital, where he serves as the head of the Benign Pathology Unit, conducting consultations and surgeries for various conditions such as uterine myomatosis, pelvic floor issues, endometrial pathology, endometriosis, genital aging, and cervical and lower genital tract pathology. He has extensive experience in hysteroscopy, vaginal surgery and various approaches to conditions requiring transabdominal intervention: laparotomic, laparoscopic, and robotic surgery. He is accredited as a robotic surgeon by the European Society for Gynecological Surgery (SERGS) and holds the European Diploma in Gynecological Endoscopy (GESEA, ESGE). Currently, he is involved in studies on regenerative treatment of the lower genital tract using CO2 laser therapy or PRP, addressing the effects of aging and their impact on patients' quality of life.
He dedicates his teaching efforts as an associate medical professor at the University of Barcelona, also serving as the coordinator of postgraduate education. Actively involved in resident education, he collaborates with various pharmaceutical and surgical technology industries through seminars, webinars, and symposiums.
As a researcher, he actively participates in various impact studies related to the molecular diagnosis of endometrial and ovarian cancers, minimally invasive techniques for treating endometriosis, the effects of diet on endometrial cancer, and the utility of AI in diagnosing various uterine pathologies, among others.